1. Home
  2. ADPT vs INDB Comparison

ADPT vs INDB Comparison

Compare ADPT & INDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

N/A

Current Price

$28.14

Market Cap

4.5B

Sector

Health Care

ML Signal

N/A

Logo Independent Bank Corp.

INDB

Independent Bank Corp.

HOLD

Current Price

$83.56

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADPT
INDB
Founded
2009
1907
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.8B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
ADPT
INDB
Price
$28.14
$83.56
Analyst Decision
Strong Buy
Buy
Analyst Count
8
7
Target Price
$30.21
★ $94.00
AVG Volume (30 Days)
★ 2.0M
457.7K
Earning Date
11-04-2026
10-15-2026
Dividend Yield
N/A
★ 3.06%
EPS Growth
★ 63.89
N/A
EPS
N/A
★ 3.33
Revenue
★ $276,976,000.00
N/A
Revenue This Year
$5.03
$20.59
Revenue Next Year
$22.97
$4.74
P/E Ratio
★ N/A
$25.10
Revenue Growth
★ 54.77
N/A
52 Week Low
$12.00
$65.68
52 Week High
$30.74
$87.50

Technical Indicators

Market Signals
Indicator
ADPT
INDB
Relative Strength Index (RSI) 59.54 62.83
Support Level $23.73 $82.49
Resistance Level $30.35 $84.02
Average True Range (ATR) 1.47 1.59
MACD 0.32 0.66
Stochastic Oscillator 83.27 87.04

Price Performance

Historical Comparison
ADPT
INDB

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

Share on Social Networks: